Advertisement

The performance and safety of bilateral salpingectomy for ovarian cancer prevention in the United States

Published:October 31, 2016DOI:https://doi.org/10.1016/j.ajog.2016.10.035

      Background

      Ovarian cancer is the leading cause of death due to gynecologic malignancy and the fifth most common cause of cancer deaths in developed countries. Recent evidence has indicated that the most common and lethal form of ovarian cancer originates in the distal fallopian tube, and recommendations for surgical removal of the fallopian tube (bilateral salpingectomy) at the time of other gynecologic surgeries (particularly hysterectomy and tubal sterilization) have been made, most recently by the American Congress of Obstetricians and Gynecologists.

      Objective

      We sought to assess the uptake and perioperative safety of bilateral salpingectomy at the time of hysterectomy and tubal sterilization in the United States and to examine the factors associated with increased likelihood of bilateral salpingectomy.

      Study Design

      The Nationwide Inpatient Sample was used to identify all girls and women 15 years or older without gynecologic cancer who underwent inpatient hysterectomy or tubal sterilization, with and without bilateral salpingectomy, from 2008 through 2013. Weighted estimates of national rates of these procedures were calculated and the number of procedures performed estimated. Safety was assessed by examining rates of blood transfusions, perioperative complications, postprocedural infection, and fever, and adjusted odds ratios were calculated comparing hysterectomy with salpingectomy with hysterectomy alone.

      Results

      We included 425,180 girls and women who underwent inpatient hysterectomy from 2008 through 2013 representing a national cohort of 2,036,449 (95% confidence interval, 1,959,374–2,113,525) girls and women. There was an increase in the uptake of hysterectomy with bilateral salpingectomy of 371% across the study period, with 7.7% of all hysterectomies including bilateral salpingectomy in 2013 (15.8% among girls and women retaining their ovaries). There were only 1195 salpingectomies for sterilization, thus no further comparisons were possible. In the girls and women who had hysterectomy with bilateral salpingectomy, there was no increased risk for blood transfusion (adjusted odds ratio, 0.95; 95% confidence interval, 0.86–1.05) postoperative complications (adjusted odds ratio, 0.97; 95% confidence interval, 0.88–1.07), postoperative infections (adjusted odds ratio, 1.26; 95% confidence interval, 0.90–1.78), or fevers (adjusted odds ratio, 1.33; 95% confidence interval, 1.00–1.77) compared with women undergoing hysterectomy alone. Younger age, private for-profit hospital setting, larger hospital size, and indication for hysterectomy were all associated with increased likelihood of getting a hysterectomy with bilateral salpingectomy in women retaining their ovaries.

      Conclusion

      Our results suggest that hysterectomy with bilateral salpingectomy is significantly increasing in the United States and is not associated with increased risks of postoperative complications.

      Key words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Obstetrics & Gynecology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Rosenthal A.N.
        • Fraser L.
        • Manchanda R.
        • et al.
        Results of annual screening in phase I of the United Kingdom familial ovarian cancer screening study highlight the need for strict adherence to screening schedule.
        J Clin Oncol. 2013; 31: 49-57
        • Buys S.S.
        • Partridge E.
        • Black A.
        • et al.
        Effect of screening on ovarian cancer mortality: the prostate, lung, colorectal and ovarian (PLCO) cancer screening randomized controlled trial.
        JAMA. 2011; 305: 2295-2303
        • Kobayashi H.
        • Yamada Y.
        • Sado T.
        • et al.
        A randomized study of screening for ovarian cancer: a multicenter study in Japan.
        Int J Gynecol Cancer. 2008; 18: 414-420
        • Menon U.
        • Gentry-Maharaj A.
        • Hallett R.
        • et al.
        Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK collaborative trial of ovarian cancer screening (UKCTOCS).
        Lancet Oncol. 2009; 10: 327-340
        • Menon U.
        • Ryan A.
        • Kalsi J.
        • et al.
        Risk algorithm using serial biomarker measurements doubles the number of screen-detected cancers compared with a single-threshold rule in the United Kingdom collaborative trial of ovarian cancer screening.
        J Clin Oncol. 2015; 33: 2062-2071
        • Kobel M.
        • Kalloger S.E.
        • Huntsman D.G.
        • et al.
        Differences in tumor type in low-stage versus high-stage ovarian carcinomas.
        Int J Gynecol Pathol. 2010; 29: 203-211
        • Gao F.F.
        • Bhargava R.
        • Yang H.
        • Li Z.
        • Zhao C.
        Clinicopathologic study of serous tubal intraepithelial carcinoma with invasive carcinoma: is serous tubal intraepithelial carcinoma a reliable feature for determining the organ of origin?.
        Hum Pathol. 2013; 44: 1534-1543
        • Crum C.P.
        • Drapkin R.
        • Miron A.
        • et al.
        The distal fallopian tube: a new model for pelvic serous carcinogenesis.
        Curr Opin Obstet Gynecol. 2007; 19: 3-9
        • Karst A.M.
        • Levanon K.
        • Drapkin R.
        Modeling high-grade serous ovarian carcinogenesis from the fallopian tube.
        Proc Natl Acad Sci U S A. 2011; 108: 7547-7552
        • Singh N.
        • Gilks C.B.
        • Wilkinson N.
        • McCluggage W.G.
        Assessment of a new system for primary site assignment in high-grade serous carcinoma of the fallopian tube, ovary, and peritoneum.
        Histopathology. 2015; 67: 331-337
      1. The Society of Gynecologic Oncology of Canada. GOC statement regarding salpingectomy and ovarian cancer prevention. 2011. Available at https://g-o-c.org/wp-content/uploads/2015/09/7GOCStmt_2011Sep_SalpOvCa_EN.pdf. Accessed November 8, 2016.

      2. Society of Gynecologic Oncology. Salpingectomy for ovarian cancer. SGO Clinical practice statement. 2013. Available at https://www.sgo.org/clinical-practice/guidelines/sgo-clinical-practice-statement-salpingectomy-for-ovarian-cancer-prevention/. Accessed November 8, 2016.

        • American College of Obstetrics and Gynecology
        Salpingectomy for ovarian cancer prevention. Committee opinion no. 620.
        Obstet Gynecol. 2015; 125: 279-281
        • Hicks-Courant K.D.
        Growth in salpingectomy rates in the United States since 2000.
        Am J Obstet Gynecol. 2016; 215: 666-667
        • Mikhail E.
        • Salemi J.L.
        • Mogos M.F.
        • Hart S.
        • Salihu H.M.
        • Imudia A.N.
        National trends of adnexal surgeries at the time of hysterectomy for benign indication, United States, 1998-2011.
        Am J Obstet Gynecol. 2015; 213: 713.e1-713.e13
        • Houchens R.L.
        • Ross D.N.
        • Elixhauser A.
        • Jiang J.
        Nationwide Inpatient Sample redesign: final report.
        Agency for Healthcare Research and Quality, Maryland2014
      3. University of British Columbia Board of Governors. Research Involving Human Participants. Policy no. 89. 2012. Vancouver, BC, Canada.

        • McAlpine J.N.
        • Hanley G.E.
        • Woo M.M.
        • et al.
        Opportunistic salpingectomy: uptake, risks, and complications of a regional initiative for ovarian cancer prevention.
        Am J Obstet Gynecol. 2014; 210: 471.e1-471.e11
        • Wright J.D.
        • Herzog T.J.
        • Tsui J.
        • et al.
        Nationwide trends in the performance of inpatient hysterectomy in the United States.
        Obstet Gynecol. 2013; 122: 233-241
        • Parker W.H.
        • Broder M.S.
        • Chang E.
        • et al.
        Ovarian conservation at the time of hysterectomy and long-term health outcomes in the nurses' health study.
        Obstet Gynecol. 2009; 113: 1027-1037
        • Parker W.H.
        • Feskanich D.
        • Broder M.S.
        • et al.
        Long-term mortality associated with oophorectomy compared with ovarian conservation in the nurses' health study.
        Obstet Gynecol. 2013; 121: 709-716
        • Hanley G.
        • McAlpine J.
        • Kwon J.
        • Mitchell G.
        Opportunistic salpingectomy for ovarian cancer prevention.
        Gynaecol Oncol Res Pract. 2015; 2: 1-9
        • Gill S.E.
        • Mills B.B.
        Physician opinions regarding elective bilateral salpingectomy with hysterectomy and for sterilization.
        J Minim Invasive Gynecol. 2013; 20: 517-521
        • Lessard-Anderson C.R.
        • Handlogten K.S.
        • Molitor R.J.
        • et al.
        Effect of tubal sterilization technique on risk of serous epithelial ovarian and primary peritoneal carcinoma.
        Gynecol Oncol. 2014; 135: 423-427
        • Madsen C.
        • Baandrup L.
        • Dehlendorff C.
        • Kjaer S.K.
        Tubal ligation and salpingectomy and the risk of epithelial ovarian cancer and borderline ovarian tumors: a nationwide case-control study.
        Acta Obstet Gynecol Scand. 2015; 94: 86-94
        • Falconer H.
        • Yin L.
        • Gronberg H.
        • Altman D.
        Ovarian cancer risk after salpingectomy: a nationwide population-based study.
        J Natl Cancer Inst. 2015; 107: 1-6
        • Yoon S.H.
        • Kim S.N.
        • Shim S.H.
        • Kang S.B.
        • Lee S.J.
        Bilateral salpingectomy can reduce the risk of ovarian cancer in the general population: a meta-analysis.
        Eur J Cancer. 2016; 55: 38-46
        • Morelli M.
        • Venturella R.
        • Mocciaro R.
        • et al.
        Prophylactic salpingectomy in premenopausal low-risk women for ovarian cancer: primum non nocere.
        Gynecol Oncol. 2013; 129: 448-451
        • Findley A.D.
        • Siedhoff M.T.
        • Hobbs K.A.
        • et al.
        Short-term effects of salpingectomy during laparoscopic hysterectomy on ovarian reserve: a pilot randomized controlled trial.
        Fertil Steril. 2013; 100: 1704-1708